Protagenic Therapeutics, Inc.\new (PTIX): Net Income
$1.37M
Year ended 2026-03-31
$5.46M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $1.37M | n/m | 2026-08-14, From 2025-04-01 |
| 2025-03-31 | -$3.59M | n/a | 2026-08-14, From 2024-04-01 |
| No annual figure between 2023-12-31 and 2025-03-31. | |||
| 2023-12-31 | -$5.00M | n/m | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | -$3.56M | n/m | 2024-05-14, From 2022-01-01 |
| 2021-12-31 | -$4.52M | n/m | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | -$2.55M | n/m | 2022-04-07, From 2020-01-01 |
| 2019-12-31 | -$1.75M | n/m | 2021-03-25, From 2019-01-01 |
| 2018-12-31 | -$2.56M | n/m | 2020-04-29, From 2018-01-01 |
| 2017-12-31 | -$2.26M | n/m | 2019-03-29, From 2017-01-01 |
| 2016-12-31 | -$2.28M | n/m | 2018-04-02, From 2016-01-01 |
| 2015-12-31 | -$1.02M | n/a | 2017-05-08, From 2015-01-01 |
| No annual figure between 2014-06-30 and 2015-12-31. | |||
| 2014-06-30 | -$1.08M | n/a | 2015-09-25, From 2013-07-12 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Protagenic Therapeutics, Inc.\new (PTIX) | 2026-03-31 | $1.37M | n/m |
| Bio-Path Holdings, Inc. (BPTH) | 2024-12-31 | -$9.89M | n/m |
| Pulmatrix, Inc. (PULM) | 2025-12-31 | -$5.16M | n/m |
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | -$11.90M | n/m |
| Cadrenal Therapeutics, Inc. (CVKD) | 2025-12-31 | -$13.24M | n/m |
| Hepion Pharmaceuticals, Inc. (HEPA) | 2025-12-31 | -$8.28M | n/m |
| InMed Pharmaceuticals Inc. (INM) | 2026-06-30 | -$12.56M | n/m |
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | -$4.18M | n/m |
| Avenue Therapeutics, Inc. (ATXI) | 2025-12-31 | -$2.91M | n/m |
Compare PTIX, BPTH, PULM, LEXX side by side · Screen every company in Pharmaceutical Preparations ↗